tradingkey.logo

InfuSystem Holdings Inc

INFU
7.720USD
+0.150+1.98%
Close 02/06, 16:00ETQuotes delayed by 15 min
156.93MMarket Cap
29.15P/E TTM

InfuSystem Holdings Inc

7.720
+0.150+1.98%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of InfuSystem Holdings Inc

Currency: USD Updated: 2026-02-06

Key Insights

InfuSystem Holdings Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 62 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 14.20.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

InfuSystem Holdings Inc's Score

Industry at a Glance

Industry Ranking
62 / 205
Overall Ranking
171 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

InfuSystem Holdings Inc Highlights

StrengthsRisks
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.70% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 134.86M.
Undervalued
The company’s latest PE is 29.15, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 15.52M shares, decreasing 11.77% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 981.58K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.54.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
14.200
Target Price
+87.58%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of InfuSystem Holdings Inc is 8.13, ranking 55 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 36.49M, representing a year-over-year increase of 3.31%, while its net profit experienced a year-over-year increase of 25.01%.

Score

Industry at a Glance

Previous score
8.13
Change
0

Financials

6.27

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

10.00

Operational Efficiency

9.32

Growth Potential

7.75

Shareholder Returns

7.30

InfuSystem Holdings Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of InfuSystem Holdings Inc is 7.15, ranking 121 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 29.15, which is 42361.64% below the recent high of 12379.31 and 22.70% above the recent low of 22.54.

Score

Industry at a Glance

Previous score
7.15
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 62/205
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of InfuSystem Holdings Inc is 8.40, ranking 32 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 15.00, with a high of 15.00 and a low of 12.00.

Score

Industry at a Glance

Previous score
8.40
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
14.200
Target Price
+87.58%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

114
Total
6
Median
9
Average
Company name
Ratings
Analysts
InfuSystem Holdings Inc
INFU
5
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Medtronic PLC
MDT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of InfuSystem Holdings Inc is 6.63, ranking 112 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 8.64 and the support level at 7.16, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.45
Change
0.18

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(1)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.127
Sell
RSI(14)
35.337
Neutral
STOCH(KDJ)(9,3,3)
14.577
Oversold
ATR(14)
0.402
Low Volatility
CCI(14)
-145.105
Sell
Williams %R
85.517
Oversold
TRIX(12,20)
-0.445
Sell
StochRSI(14)
36.164
Buy
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
7.916
Sell
MA10
8.113
Sell
MA20
8.365
Sell
MA50
8.797
Sell
MA100
9.357
Sell
MA200
8.111
Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of InfuSystem Holdings Inc is 7.00, ranking 80 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 76.31%, representing a quarter-over-quarter increase of 0.82%. The largest institutional shareholder is The Vanguard, holding a total of 981.58K shares, representing 4.83% of shares outstanding, with 6.29% decrease in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Acuitas Investments LLC
1.03M
-16.01%
Minerva Advisors LLC
1.03M
--
The Vanguard Group, Inc.
Star Investors
976.18K
+1.94%
Sansone Advisors, LLC
939.29K
-17.84%
Punch & Associates Investment Management, Inc.
809.75K
-7.83%
First Eagle Investment Management, L.L.C.
Star Investors
801.87K
-11.92%
Renaissance Technologies LLC
Star Investors
575.71K
+25.26%
Dimensional Fund Advisors, L.P.
569.24K
+0.78%
AWM Investment Company, Inc.
561.66K
-55.85%
Dilorio (Richard)
485.99K
+4.61%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of InfuSystem Holdings Inc is 4.01, ranking 114 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.69. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
4.01
Change
0
Beta vs S&P 500 index
1.69
VaR
+4.79%
240-Day Maximum Drawdown
+41.10%
240-Day Volatility
+57.30%

Return

Best Daily Return
60 days
+5.13%
120 days
+6.67%
5 years
+18.12%
Worst Daily Return
60 days
-6.47%
120 days
-9.04%
5 years
-26.47%
Sharpe Ratio
60 days
-2.35
120 days
-0.82
5 years
-0.15

Risk Assessment

Maximum Drawdown
240 days
+41.10%
3 years
+58.22%
5 years
+79.45%
Return-to-Drawdown Ratio
240 days
+0.05
3 years
-0.02
5 years
-0.17
Skewness
240 days
+1.05
3 years
+0.82
5 years
-0.23

Volatility

Realised Volatility
240 days
+57.30%
5 years
+55.42%
Standardised True Range
240 days
+4.88%
5 years
+6.01%
Downside Risk-Adjusted Return
120 days
-114.51%
240 days
-114.51%
Maximum Daily Upside Volatility
60 days
+26.13%
Maximum Daily Downside Volatility
60 days
+30.02%

Liquidity

Average Turnover Rate
60 days
+1.19%
120 days
+0.96%
5 years
--
Turnover Deviation
20 days
+254.03%
60 days
+156.67%
120 days
+107.21%

Peer Comparison

Healthcare Equipment & Supplies
InfuSystem Holdings Inc
InfuSystem Holdings Inc
INFU
7.21 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
Align Technology Inc
ALGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI